Bimekizumab Efficacy through One Year in Patients With Moderate to Severe Plaque Psoriasis in Subgroups Defined by Prior Biologic Treatment: Pooled Results from Four Phase 3 3b Trials . J of Skin 2022, 6 (6), s64. https://doi.org/10.25251/skin.6.supp.64.